Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3 [Phase 2]
Phase 2 open-label study evaluating sofosbuvir (PSI-7977) plus ribavirin, with or without pegylated interferon, in treatment-naïve hepatitis…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects [Phase 2]
Phase 2 trial updates the safety and efficacy of the LDV/SOF fixed-dose combination with or without ribavirin in chronic hepatitis C genotyp…
-
FDA approval · 2014-11-14FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B [Phase 4]
Phase 4 study update on maraviroc in HIV-infected subjects co-infected with hepatitis C and/or hepatitis B. Results for the study were poste…
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: The Boceprevir and Sildenafil Pharmacokinetics Study [Phase 1]
A Phase 1 pharmacokinetics study evaluating the interaction between boceprevir and sildenafil in Hepatitis C patients has been completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients [Phase 1]
Phase 1 trial assessing safety, pharmacokinetics and preliminary efficacy of SCY-635 given for 15 days in patients with chronic hepatitis C;…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Psychoeducation for Hepatitis and Alcohol Behaviors [NA]
A completed clinical trial studying psychoeducation to influence hepatitis C and alcohol-use behaviors.
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients [Phase 3]
Phase 3 trial evaluating MP-424 with peginterferon alfa-2b and ribavirin in relapser genotype 2 chronic hepatitis C patients; results were p…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of MP-424 with peginterferon alfa-2b and ribavirin in non-responder genotype 2 chronic hepa…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1 [Phase 3]
Phase 3 study evaluating the safety, tolerability and efficacy of Simeprevir (TMC435) with pegylated interferon alfa-2a and ribavirin in chr…
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients [Phase 2]
Phase 2 trial evaluating the combination of TMC435 with sofosbuvir (GS-7977) in chronic hepatitis C genotype 1 infection, including prior nu…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test
The trial assesses the clinical performance of the Abbott RealTime HCV Genotype II Test for detecting and genotyping hepatitis C virus.
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis [Phase 2]
Phase 2 study evaluating the efficacy and safety of a quadruple therapy (VX-222, telaprevir, peginterferon-alfa-2a, ribavirin) in adults wit…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C [Phase 2]
The document notes the completion of a Phase II dose-escalation study of PEG-IFN-SA with ribavirin in interferon-naive patients with chronic…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation [NA]
This clinical trial update reports on the role of tissue C4d in distinguishing acute rejection from hepatitis C recurrence after liver trans…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin [Phase 2]
Phase 2 trial evaluating boceprevir in HIV-Hepatitis C coinfected patients who failed prior peg-interferon/ribavirin therapy; the study is c…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044) [Phase 3]
Phase 3 trial of vaniprevir plus pegylated interferon and ribavirin in Japanese patients with chronic hepatitis C who relapsed after prior t…
-
FDA approval · 2014-10-10FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Original Application (Asegua Therapeutics LLC)
FDA approved Ledipasvir and Sofosbuvir under an Original Application filed by Asegua Therapeutics LLC for the treatment of hepatitis C.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 [Phase 1]
Phase 1 trial evaluating the food effect of a fixed-dose combination of daclatasvir, asunaprevir, and BMS-791325 in Hepatitis C.
-
CLINICAL_TRIALS research · 2014-10-10Clinical Trial Update: Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection [NA]
This clinical trial update discusses the use of ribavirin off-label for mucocutaneous extrahepatic manifestations of hepatitis C, such as li…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045) [Phase 3]
A Phase 3 trial in Japanese non-responders to prior Hepatitis C treatment assessing vaniprevir plus PegIntron and ribavirin has completed wi…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection [Phase 3]
Phase 3 results of the combination of sofosbuvir and ribavirin in treatment-naive and treatment-experienced adults with chronic hepatitis C …
-
CLINICAL_TRIALS withdrawal · 2014-10-08Clinical Trial Update: SIMpill Medication Dispensing Device in the Treatment of HCV
The clinical trial evaluating the SIMpill Medication Dispensing Device for chronic hepatitis C infection has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614) [Phase 1]
Phase 1 pharmacokinetics study of boceprevir in pediatric patients with chronic hepatitis C genotype 1; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients [Phase 3]
A Phase 3 trial evaluating peginterferon alfa-2b for chronic hepatitis C in Chinese patients has completed, examining efficacy and safety ou…